SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolvere Regulatory News (VLE)

Share Price Information for Volvere (VLE)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    0.00 (0.00%)
Bid:
2,240.00
Ask:
2,400.00
Spread: 160.00 (7.143%)
Market Cap: £51.04m
VLE Live PriceLast checked at - London Stock Exchange

Intraday Volvere Share Chart

Directors' Dealings

18 Jul 2008 07:00

RNS Number : 3578Z
Volvere PLC
18 July 2008
 



Volvere PLC ("Volvere" or the "Company")

Directors' Dealings

The Company announces that it has received notification on 17 July 2008 from Lord Kalms of Edgware, Jonathan Lander, Nicholas Lander, Richard Kalms, Neil Ashley and David Buchler who are all directors of the Company that on that day they acquired in aggregate 243,750 Ordinary Shares of GBP0.0000001 each in the Company at a price of GBP 0.70 per Ordinary Share. Their respective purchases and resultant holdings are as follows:

Lord Kalms acquired 58,992 Ordinary Shares and now has an interest in 458,992 Ordinary Shares representing 8.08% of the issued Ordinary Share capital of the Company. In addition, Lord Kalms holds 2,630 A Shares of GBP 0.49999995 each and 2,630 B Shares of GBP0.49999995 each in the capital of the Company. Neither of these classes of share capital is traded on AIM.

Jonathan Lander acquired 58,992 Ordinary Shares and now has an interest in 437,742 Ordinary Shares representing 7.71% of the issued Ordinary Share capital of the Company. In addition, Jonathan Lander holds 14,500 A Shares of GBP 0.49999995 each and 14,500 B Shares of GBP0.49999995 each in the capital of the Company. Neither of these classes of share capital is traded on AIM.

Nicholas Lander acquired 58,992 Ordinary Shares and now has an interest in 178,992 Ordinary Shares representing 3.15% of the issued Ordinary Share capital of the Company. In addition, Nicholas Lander holds 10,758 A Shares of GBP 0.49999995 each and 10,758 B Shares of GBP0.49999995 each in the capital of the Company. Neither of these classes of share capital is traded on AIM.

Richard Kalms acquired 14,748 Ordinary Shares and now has an interest in 264,748 Ordinary Shares representing 4.66% of the issued Ordinary Share capital of the Company. In addition, Richard Kalms holds 6,987 A Shares of GBP 0.49999995 each and 6,987 B Shares of GBP0.49999995 each in the capital of the Company. Neither of these classes of share capital is traded on AIM.

Neil Ashley acquired 32,773 Ordinary Shares and now has an interest in 542,773 Ordinary Shares representing 9.56% of the issued Ordinary Share capital of the Company. In addition, Neil Ashley holds 3,880 A Shares of GBP 0.49999995 each and 3,880 B Shares of GBP0.49999995 each in the capital of the Company. Neither of these classes of share capital is traded on AIM. Neil Ashley is a trustee of the Ashley Grandchildren's 2003 Settlement whose holdings are included in the above.

David Buchler acquired 19,253 Ordinary Shares and now has an interest in 68,238 Ordinary Shares representing 1.20% of the issued Ordinary Share capital of the Company. In addition, David Buchler holds options over 31,000 Ordinary Shares at an exercise price of £1.875, exercisable until 31 December 2014.

For further information:

Volvere plc

Nick Lander, Chief Operating and Financial Officer

020 7979 7596

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSRRMPTMMABBPP
Date   Source Headline
21st May 202610:30 amRNSPosting of Annual Report and Notice of AGM
20th May 20267:00 amRNSHolding(s) in Company
18th May 20269:41 amRNSHolding(s) in Company
15th May 20263:30 pmRNSHolding(s) in Company
15th May 20267:00 amRNSFinal Results
7th May 20263:09 pmRNSHolding(s) in Company
7th May 20263:08 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSTrading Update and Notice of Final Results
17th Mar 20267:00 amRNSTrading Update and Notice of Final Results
18th Feb 20265:00 pmRNSHolding(s) in Company
4th Dec 20257:00 amRNSTransaction in Own Shares
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSHalf-year Report
26th Jun 20255:15 pmRNSResult of AGM
16th May 20257:00 amRNSFinal Results
26th Mar 20255:45 pmRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTrading Update and Notice of Final Results
25th Oct 20245:05 pmRNSDirector/PDMR Shareholding
10th Oct 20241:10 pmRNSHolding(s) in Company
20th Sep 20247:00 amRNSTransaction in Own Shares
13th Sep 20247:00 amRNSHalf-year Report
17th Jul 20249:45 amRNSTransaction in Own Shares
28th Jun 20246:25 pmRNSTransaction in Own Shares
28th Jun 20246:00 pmRNSResult of AGM
11th Jun 20247:00 amRNSTransaction in Own Shares
31st May 20241:30 pmRNSTransaction in Own Shares
30th May 20247:00 amRNSPosting of Annual Report and Notice of AGM
30th May 20247:00 amRNSTransaction in Own Shares
22nd May 20247:00 amRNSFinal results to 31 December 2023
14th Mar 20247:00 amRNSHolding(s) in Company
13th Mar 20245:00 pmRNSHolding(s) in Company
13th Mar 202412:30 pmRNSTransaction in Own Shares
12th Mar 20248:00 amRNSTrading Update and Notice of Final Results
13th Nov 20234:20 pmRNSHolding(s) in Company
9th Oct 20235:39 pmRNSTransaction in Own Shares
22nd Sep 202312:15 pmRNSTransaction in Own Shares
19th Sep 20237:00 amRNSAppointment of Director
19th Sep 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSDeath of Director
28th Jul 202312:00 pmRNSTransaction in Own Shares
11th Jul 202310:52 amRNSTransaction in Own Shares
26th Jun 20236:00 pmRNSResult of AGM
20th Jun 20234:43 pmRNSHolding(s) in Company
6th Jun 20232:20 pmRNSTransaction in Own Shares
2nd Jun 20237:00 amRNSTransaction in Own Shares
1st Jun 20239:44 amRNSPosting of Annual Report and Notice of AGM
25th May 20237:00 amRNSFinal results to 31 December 2022
11th Apr 202311:10 amRNSTransaction in Own Shares
3rd Apr 20232:47 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.